Peptilogics

Pittsburgh, United States

Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.

$78.0M raised

Oct 2025

Series B

Top Investors

Founders FundPresight CapitalNarya CapitalInnovation WorksAAF Management Ltd.

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Peptilogics raised?

Peptilogics has raised $78.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.

Who are Peptilogics's investors?

Peptilogics's investors include Founders Fund, Presight Capital, Narya Capital, Innovation Works, AAF Management Ltd..

Where is Peptilogics headquartered?

Peptilogics is headquartered in Pittsburgh, United States.

What does Peptilogics do?

Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.

What stage is Peptilogics at?

Peptilogics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 16, 2025.

MLA

"Peptilogics — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/peptilogics. Accessed June 4, 2026.

APA

VCBacked. (2025). Peptilogics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/peptilogics

Wikipedia (cite web)

{{cite web |title=Peptilogics — Funding & Investors |url=https://www.vcbacked.co/company/peptilogics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 16, 2025.